{
"bcoid": "GLY_000320",
"title": "Human Protein Reactions (Reactome)",
"description": "The Human Protein Reactions (Reactome) dataset contains reactions information for pathways for human ...",
"filename": "human_protein_reactions_reactome.csv",
"filetype": "csv",
"categories": {
"species": "Homo sapiens",
"molecule": "Protein",
"tags": "Reactions Reactome",
"file_type": "csv",
"status": "Reviewed",
"scope": "internal"
},
"minitable": {
"content": [
[
"R-HSA-903161...",
"p-S133 CREB1..."
],
[
"R-HSA-903161...",
"p-S133 CREB1..."
]
],
"headers": [
"reaction_id...",
"reaction_nam..."
],
"colwidth": [
"40%",
"20%"
]
},
"sampledata": {
"type": "table",
"data": [
[
{
"type": "string",
"label": "reaction_id"
},
{
"type": "string",
"label": "reaction_name"
},
{
"type": "string",
"label": "cellular_location"
},
{
"type": "string",
"label": "pmid"
},
{
"type": "string",
"label": "pathway_id"
},
{
"type": "string",
"label": "equation"
},
{
"type": "string",
"label": "reaction_summary"
}
],
[
"R-HSA-9031610",
"p-S133 CREB1, MEF2D and SRF bind the ARC gene",
"nucleoplasm",
"19116276",
"R-HSA-9031628",
"",
"Activity-responsive transcription of the ARC gene is driven in part by a Synaptic Activity Response Element located ~7kb upstream of the transcription start site. This element is bound by CREB, SRF and MEF2D as assessed by EMSA and ChIP in mouse cells (Kawashima et al, 2009). SARE-driven ARC expression is responsive to stimulation through AMPAR and NMDAR activity, and depends on CaMK and MAPK signaling pathways, consistent with previous studies (Kawashima et al, 2009; Falvell et al, 2006; Ramanan et al, 2005; Bourtchuladze et al, 1994; reviewed in Inoue et al, 2010; Finkbeiner et al, 1997; Epstein and Finkbeiner, 2018). Additional binding sites for SRF, MEF2D and ELK1 were also identified in another study, along with putative binding sites for an as-yet uncharacterized Zeste-like mammalian homologue (Pintchovski et al, 2006)."
],
[
"R-HSA-9031610",
"p-S133 CREB1, MEF2D and SRF bind the ARC gene",
"nucleoplasm",
" 19193899",
"R-HSA-9031628",
"",
"Activity-responsive transcription of the ARC gene is driven in part by a Synaptic Activity Response Element located ~7kb upstream of the transcription start site. This element is bound by CREB, SRF and MEF2D as assessed by EMSA and ChIP in mouse cells (Kawashima et al, 2009). SARE-driven ARC expression is responsive to stimulation through AMPAR and NMDAR activity, and depends on CaMK and MAPK signaling pathways, consistent with previous studies (Kawashima et al, 2009; Falvell et al, 2006; Ramanan et al, 2005; Bourtchuladze et al, 1994; reviewed in Inoue et al, 2010; Finkbeiner et al, 1997; Epstein and Finkbeiner, 2018). Additional binding sites for SRF, MEF2D and ELK1 were also identified in another study, along with putative binding sites for an as-yet uncharacterized Zeste-like mammalian homologue (Pintchovski et al, 2006)."
],
[
"R-HSA-9031610",
"p-S133 CREB1, MEF2D and SRF bind the ARC gene",
"nucleoplasm",
" 29559111",
"R-HSA-9031628",
"",
"Activity-responsive transcription of the ARC gene is driven in part by a Synaptic Activity Response Element located ~7kb upstream of the transcription start site. This element is bound by CREB, SRF and MEF2D as assessed by EMSA and ChIP in mouse cells (Kawashima et al, 2009). SARE-driven ARC expression is responsive to stimulation through AMPAR and NMDAR activity, and depends on CaMK and MAPK signaling pathways, consistent with previous studies (Kawashima et al, 2009; Falvell et al, 2006; Ramanan et al, 2005; Bourtchuladze et al, 1994; reviewed in Inoue et al, 2010; Finkbeiner et al, 1997; Epstein and Finkbeiner, 2018). Additional binding sites for SRF, MEF2D and ELK1 were also identified in another study, along with putative binding sites for an as-yet uncharacterized Zeste-like mammalian homologue (Pintchovski et al, 2006)."
],
[
"R-HSA-9031610",
"p-S133 CREB1, MEF2D and SRF bind the ARC gene",
"nucleoplasm",
" 15880109",
"R-HSA-9031628",
"",
"Activity-responsive transcription of the ARC gene is driven in part by a Synaptic Activity Response Element located ~7kb upstream of the transcription start site. This element is bound by CREB, SRF and MEF2D as assessed by EMSA and ChIP in mouse cells (Kawashima et al, 2009). SARE-driven ARC expression is responsive to stimulation through AMPAR and NMDAR activity, and depends on CaMK and MAPK signaling pathways, consistent with previous studies (Kawashima et al, 2009; Falvell et al, 2006; Ramanan et al, 2005; Bourtchuladze et al, 1994; reviewed in Inoue et al, 2010; Finkbeiner et al, 1997; Epstein and Finkbeiner, 2018). Additional binding sites for SRF, MEF2D and ELK1 were also identified in another study, along with putative binding sites for an as-yet uncharacterized Zeste-like mammalian homologue (Pintchovski et al, 2006)."
],
[
"R-HSA-9031610",
"p-S133 CREB1, MEF2D and SRF bind the ARC gene",
"nucleoplasm",
" 16484497",
"R-HSA-9031628",
"",
"Activity-responsive transcription of the ARC gene is driven in part by a Synaptic Activity Response Element located ~7kb upstream of the transcription start site. This element is bound by CREB, SRF and MEF2D as assessed by EMSA and ChIP in mouse cells (Kawashima et al, 2009). SARE-driven ARC expression is responsive to stimulation through AMPAR and NMDAR activity, and depends on CaMK and MAPK signaling pathways, consistent with previous studies (Kawashima et al, 2009; Falvell et al, 2006; Ramanan et al, 2005; Bourtchuladze et al, 1994; reviewed in Inoue et al, 2010; Finkbeiner et al, 1997; Epstein and Finkbeiner, 2018). Additional binding sites for SRF, MEF2D and ELK1 were also identified in another study, along with putative binding sites for an as-yet uncharacterized Zeste-like mammalian homologue (Pintchovski et al, 2006)."
],
[
"R-HSA-9031610",
"p-S133 CREB1, MEF2D and SRF bind the ARC gene",
"nucleoplasm",
" 21057636",
"R-HSA-9031628",
"",
"Activity-responsive transcription of the ARC gene is driven in part by a Synaptic Activity Response Element located ~7kb upstream of the transcription start site. This element is bound by CREB, SRF and MEF2D as assessed by EMSA and ChIP in mouse cells (Kawashima et al, 2009). SARE-driven ARC expression is responsive to stimulation through AMPAR and NMDAR activity, and depends on CaMK and MAPK signaling pathways, consistent with previous studies (Kawashima et al, 2009; Falvell et al, 2006; Ramanan et al, 2005; Bourtchuladze et al, 1994; reviewed in Inoue et al, 2010; Finkbeiner et al, 1997; Epstein and Finkbeiner, 2018). Additional binding sites for SRF, MEF2D and ELK1 were also identified in another study, along with putative binding sites for an as-yet uncharacterized Zeste-like mammalian homologue (Pintchovski et al, 2006)."
],
[
"R-HSA-9031610",
"p-S133 CREB1, MEF2D and SRF bind the ARC gene",
"nucleoplasm",
" 7923378",
"R-HSA-9031628",
"",
"Activity-responsive transcription of the ARC gene is driven in part by a Synaptic Activity Response Element located ~7kb upstream of the transcription start site. This element is bound by CREB, SRF and MEF2D as assessed by EMSA and ChIP in mouse cells (Kawashima et al, 2009). SARE-driven ARC expression is responsive to stimulation through AMPAR and NMDAR activity, and depends on CaMK and MAPK signaling pathways, consistent with previous studies (Kawashima et al, 2009; Falvell et al, 2006; Ramanan et al, 2005; Bourtchuladze et al, 1994; reviewed in Inoue et al, 2010; Finkbeiner et al, 1997; Epstein and Finkbeiner, 2018). Additional binding sites for SRF, MEF2D and ELK1 were also identified in another study, along with putative binding sites for an as-yet uncharacterized Zeste-like mammalian homologue (Pintchovski et al, 2006)."
],
[
"R-HSA-9031610",
"p-S133 CREB1, MEF2D and SRF bind the ARC gene",
"nucleoplasm",
" 9390517",
"R-HSA-9031628",
"",
"Activity-responsive transcription of the ARC gene is driven in part by a Synaptic Activity Response Element located ~7kb upstream of the transcription start site. This element is bound by CREB, SRF and MEF2D as assessed by EMSA and ChIP in mouse cells (Kawashima et al, 2009). SARE-driven ARC expression is responsive to stimulation through AMPAR and NMDAR activity, and depends on CaMK and MAPK signaling pathways, consistent with previous studies (Kawashima et al, 2009; Falvell et al, 2006; Ramanan et al, 2005; Bourtchuladze et al, 1994; reviewed in Inoue et al, 2010; Finkbeiner et al, 1997; Epstein and Finkbeiner, 2018). Additional binding sites for SRF, MEF2D and ELK1 were also identified in another study, along with putative binding sites for an as-yet uncharacterized Zeste-like mammalian homologue (Pintchovski et al, 2006)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
"7624335",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 3127059",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 22065583",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 2072895",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 3672127",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 10826704",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 22053691",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 10203854",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 11018254",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 11331872",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 16187211",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 2109185",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 21326363",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 27220739",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 28275114",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 8483478",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612073",
"NGF- and MAPK-dependent EGR1, EGR2 and EGR4 expression",
"nucleoplasm",
" 9858769",
"R-HSA-9031628",
"",
"The Early Growth Response (EGR) gene family includes EGR1-4 and WT1. These Cys2-His2 zinc finger transcription factors are immediate early genes (IEG) that are rapidly turned on downstream of a number of stimuli and regulate expression of genes involved in stress response and differentiation (reviewed in Pagel and Deindl, 2001; Bahrami and Drabl\u00f8s, 2016). Roles for EGR proteins are well established in the nervous system, with EGR target genes contributing to synaptic plasticity, long-term potentiation, peripheral nerve myelination and NGF-induced neurite outgrowth (reviewed in Perez-Cadahia et al, 2011; Herdegen and Leah, 1998; O'Donovan et al, 1999).
Expression of EGR genes depends on binding of phosphorylated ternary complex factor (TCF) protein ELK1 and its transcriptional coactivator SRF (serum response factor) to their cognate DNA binding sequences in the promoters (Hooker et al, 2017; De Franco et al, 1993; Harada et al, 2001; reviewed in Herdegen and Leah, 1998). NGF-stimulated expression of EGR1 and 2 occurs downstream of sustained MAPK signaling (Millbrandt et al, 1987; Sukhatme et al, 1988; de Franco et al, 1998; Mullenbrock et al, 2011; Crosby et al, 1991; L\u00f6nn et al, 2005). In addition to SRF and TCF binding sites, the EGR1 promoter also contain consensus binding sequences for AP-1 and CREB, as well as binding sites for EGR1 protein itself (Schwachtgen et al, 2000; Thiel et al, 2000; Svaren et al, 1996; reviewed in Page; and Deindl, 2001). Expression of EGR1 is limited by a negative feedback loop mediated by the binding of a complex of EGR1 with a repressor protein of the NAB family (NGF1A binding protein) to the EGR1 binding site (Cao et al, 1990; Thiel et al, 2000; Svaren et al, 1996)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
"28076410",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 22053691",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 10203854",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 15449318",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 15542842",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 1833716",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 2040600",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 21326363",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 28286024",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 7823924",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612076",
"p-4S, T366 ELK1:SRF bind EGR1 and EGR2 gene promoters",
"nucleoplasm",
" 8483478",
"R-HSA-9031628",
"",
"Expression of Early Growth Response (EGR) genes is dependent in part on the presence of upstream serum response elements (SREs) that bind SRF (serum response factor) and its co-activator ELK1 in response to mutiptle stimuli (Quereshi et al, 1991; Alexandre et al, 1991; de Franco et al, 1993; McMahon and Monroe, 1995;Chen et al, 2004; Vickers et al, 2004; Adams et al, 2017; Esnault et al, 2017; reviewed in O'Donovan et al, 1999; P\u00e9rez-Cadah\u00eda et al, 2011; Pagel and Deindl, 2011)."
],
[
"R-HSA-9612509",
"SGK phosphorylates SRF",
"nucleoplasm",
"15733869",
"R-HSA-9031628",
"",
"Serum/glucticocorticoid kinase (SGK) phosphorylates SRF at serine residue 103 in response to multiple upstream stimuli (Tyan et al, 2008). Phosphorylation of SRF and CREB1 by SGK contributes to the SGK-dependent expression of EGR1, an immediate early gene with roles in neuronal development, (David et al, 2005; Tyan et al, 2008; reviewed in Pagel and Deindl, 2011)."
],
[
"R-HSA-9612509",
"SGK phosphorylates SRF",
"nucleoplasm",
" 18088355",
"R-HSA-9031628",
"",
"Serum/glucticocorticoid kinase (SGK) phosphorylates SRF at serine residue 103 in response to multiple upstream stimuli (Tyan et al, 2008). Phosphorylation of SRF and CREB1 by SGK contributes to the SGK-dependent expression of EGR1, an immediate early gene with roles in neuronal development, (David et al, 2005; Tyan et al, 2008; reviewed in Pagel and Deindl, 2011)."
],
[
"R-HSA-9612509",
"SGK phosphorylates SRF",
"nucleoplasm",
" 22053691",
"R-HSA-9031628",
"",
"Serum/glucticocorticoid kinase (SGK) phosphorylates SRF at serine residue 103 in response to multiple upstream stimuli (Tyan et al, 2008). Phosphorylation of SRF and CREB1 by SGK contributes to the SGK-dependent expression of EGR1, an immediate early gene with roles in neuronal development, (David et al, 2005; Tyan et al, 2008; reviewed in Pagel and Deindl, 2011)."
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
"15733869",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
" 9770464",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
" 7551568",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
" 18088355",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
" 15449318",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
" 15542842",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
" 1833716",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
" 2040600",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
" 28286024",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9612514",
"p-S133 CREB and p-S103 SRF bind the EGR1 promoter",
"nucleoplasm",
" 7823924",
"R-HSA-9031628",
"",
"Expression of EGR1 depends in part on the binding of phosphorylated CREB and SRF factors to their cognate sites in the promoter (Quereshi et al, 1991; Alexandre et al, 1991; McMahon et al, 1995; Chen et al, 2004; Vickers et al, 2004; Tyan et al, 2008; David et al, 2005; Esnault et al, 2017). Phosphorylation of CREB can be mediated by RSK proteins, MAPKAPK2 or by SGK (de Cesare et al, 1998; Bonni et al, 1995; David et al, 2005; Tyan et al, 2008). SGK-mediated phosphorylation of SRF has also been implicated in the activation of EGR1 gene expression (Tyan et al, 2008).\n"
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
"27791178",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 14966563",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 22195972",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 12750467",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 14660603",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 15659645",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 18502828",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 20622895",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 26706195",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 28167504",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 29311131",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647977",
"ICMT methylates S-Farn RAS proteins",
"endoplasmic reticulum membrane",
" 21779505",
"R-HSA-9648002",
"",
"RAS proteins undergo C-terminal carboxymethylation by isoprenylcysteine methyltransferase (ICMT) (Yang et al, 2011; Dharmaiah et al, 2016; reviewed in Gysin et al, 2011; Ahearn et al, 2018). LIke prenylation, methylation is required for plasma membrane localization and function of RAS proteins, and disruption of ICMT or interference with the methylation reaction inhibits cell growth and KRAS-dependent transformation (Chiu et al, 2004; Michaelson et al, 2005; Bergo et al, 2004; Wahlstrom et al, 2008; Winter-Vann et al, 2003). Consistent with this, a number of small molecule inhibitors of ICMT have been shown to decrease tumor proliferation (Wang et al, 2009; Manu et al, 2017; Sun et al, 2016)."
],
[
"R-HSA-9647978",
"pro-RAS proteins are farnesylated",
"cytosol, endoplasmic reticulum membrane",
"15451670",
"R-HSA-9648002",
"",
"RAS proteins are isoprenylated at a CaaX motif in the hypervariable region, where a is an aliphatic amino acid and X is any amino acid (Casey et al, 1989; Dharmaiah et al, 2016; reviewed in Ahean et al, 2018). Geranylgeranylation is favoured when X is leucine, while all other amino acids at this position favour farnesylation by farnesyltransferase (Casey et al, 1989; Reid et al, 2004)."
],
[
"R-HSA-9647978",
"pro-RAS proteins are farnesylated",
"cytosol, endoplasmic reticulum membrane",
" 27791178",
"R-HSA-9648002",
"",
"RAS proteins are isoprenylated at a CaaX motif in the hypervariable region, where a is an aliphatic amino acid and X is any amino acid (Casey et al, 1989; Dharmaiah et al, 2016; reviewed in Ahean et al, 2018). Geranylgeranylation is favoured when X is leucine, while all other amino acids at this position favour farnesylation by farnesyltransferase (Casey et al, 1989; Reid et al, 2004)."
],
[
"R-HSA-9647978",
"pro-RAS proteins are farnesylated",
"cytosol, endoplasmic reticulum membrane",
" 2682646",
"R-HSA-9648002",
"",
"RAS proteins are isoprenylated at a CaaX motif in the hypervariable region, where a is an aliphatic amino acid and X is any amino acid (Casey et al, 1989; Dharmaiah et al, 2016; reviewed in Ahean et al, 2018). Geranylgeranylation is favoured when X is leucine, while all other amino acids at this position favour farnesylation by farnesyltransferase (Casey et al, 1989; Reid et al, 2004)."
],
[
"R-HSA-9647978",
"pro-RAS proteins are farnesylated",
"cytosol, endoplasmic reticulum membrane",
" 29311131",
"R-HSA-9648002",
"",
"RAS proteins are isoprenylated at a CaaX motif in the hypervariable region, where a is an aliphatic amino acid and X is any amino acid (Casey et al, 1989; Dharmaiah et al, 2016; reviewed in Ahean et al, 2018). Geranylgeranylation is favoured when X is leucine, while all other amino acids at this position favour farnesylation by farnesyltransferase (Casey et al, 1989; Reid et al, 2004)."
],
[
"R-HSA-9647980",
"mature RAS proteins translocate to plasma membrane",
"Golgi membrane, plasma membrane",
"21779505",
"R-HSA-9648002",
"",
"After farnesylation, C-terminal proteolysis, carboxymethylation and palmitoylation, RAS proteins translocate to the plasma membrane (reviewed in Gysin et al, 2011)."
],
[
"R-HSA-9647994",
"RAS proteins are depalmitoylated",
"plasma membrane",
"16000296",
"R-HSA-9648002",
"",
"RAS proteins undergo a dynamic palmitoylation and depalmitoylation cycle that regulates their association with membranes and thus their localization and function (Hancock et al, 1989; Swarthout et al, 2005; reviewed in Gysin et al, 2011; Lin et al, 2017; Ahearn et al, 2018). Depalmitoylation is catalyzed by the acyl-protein thioesterase LYPLA1, also known as APT1, or by members of the ABHD17 family (Dekker et al, 2010; Lin and Conibear, 2015; reviewed in Lin et al, 2017). "
],
[
"R-HSA-9647994",
"RAS proteins are depalmitoylated",
"plasma membrane",
" 2661017",
"R-HSA-9648002",
"",
"RAS proteins undergo a dynamic palmitoylation and depalmitoylation cycle that regulates their association with membranes and thus their localization and function (Hancock et al, 1989; Swarthout et al, 2005; reviewed in Gysin et al, 2011; Lin et al, 2017; Ahearn et al, 2018). Depalmitoylation is catalyzed by the acyl-protein thioesterase LYPLA1, also known as APT1, or by members of the ABHD17 family (Dekker et al, 2010; Lin and Conibear, 2015; reviewed in Lin et al, 2017). "
],
[
"R-HSA-9647994",
"RAS proteins are depalmitoylated",
"plasma membrane",
" 20418879",
"R-HSA-9648002",
"",
"RAS proteins undergo a dynamic palmitoylation and depalmitoylation cycle that regulates their association with membranes and thus their localization and function (Hancock et al, 1989; Swarthout et al, 2005; reviewed in Gysin et al, 2011; Lin et al, 2017; Ahearn et al, 2018). Depalmitoylation is catalyzed by the acyl-protein thioesterase LYPLA1, also known as APT1, or by members of the ABHD17 family (Dekker et al, 2010; Lin and Conibear, 2015; reviewed in Lin et al, 2017). "
],
[
"R-HSA-9647994",
"RAS proteins are depalmitoylated",
"plasma membrane",
" 26701913",
"R-HSA-9648002",
"",
"RAS proteins undergo a dynamic palmitoylation and depalmitoylation cycle that regulates their association with membranes and thus their localization and function (Hancock et al, 1989; Swarthout et al, 2005; reviewed in Gysin et al, 2011; Lin et al, 2017; Ahearn et al, 2018). Depalmitoylation is catalyzed by the acyl-protein thioesterase LYPLA1, also known as APT1, or by members of the ABHD17 family (Dekker et al, 2010; Lin and Conibear, 2015; reviewed in Lin et al, 2017). "
],
[
"R-HSA-9647994",
"RAS proteins are depalmitoylated",
"plasma membrane",
" 28630138",
"R-HSA-9648002",
"",
"RAS proteins undergo a dynamic palmitoylation and depalmitoylation cycle that regulates their association with membranes and thus their localization and function (Hancock et al, 1989; Swarthout et al, 2005; reviewed in Gysin et al, 2011; Lin et al, 2017; Ahearn et al, 2018). Depalmitoylation is catalyzed by the acyl-protein thioesterase LYPLA1, also known as APT1, or by members of the ABHD17 family (Dekker et al, 2010; Lin and Conibear, 2015; reviewed in Lin et al, 2017). "
],
[
"R-HSA-9647994",
"RAS proteins are depalmitoylated",
"plasma membrane",
" 29311131",
"R-HSA-9648002",
"",
"RAS proteins undergo a dynamic palmitoylation and depalmitoylation cycle that regulates their association with membranes and thus their localization and function (Hancock et al, 1989; Swarthout et al, 2005; reviewed in Gysin et al, 2011; Lin et al, 2017; Ahearn et al, 2018). Depalmitoylation is catalyzed by the acyl-protein thioesterase LYPLA1, also known as APT1, or by members of the ABHD17 family (Dekker et al, 2010; Lin and Conibear, 2015; reviewed in Lin et al, 2017). "
],
[
"R-HSA-9647994",
"RAS proteins are depalmitoylated",
"plasma membrane",
" 21779505",
"R-HSA-9648002",
"",
"RAS proteins undergo a dynamic palmitoylation and depalmitoylation cycle that regulates their association with membranes and thus their localization and function (Hancock et al, 1989; Swarthout et al, 2005; reviewed in Gysin et al, 2011; Lin et al, 2017; Ahearn et al, 2018). Depalmitoylation is catalyzed by the acyl-protein thioesterase LYPLA1, also known as APT1, or by members of the ABHD17 family (Dekker et al, 2010; Lin and Conibear, 2015; reviewed in Lin et al, 2017). "
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
"10085068",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 11038283",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 19188362",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 10085069",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 10667208",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 11739732",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 12433685",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 15659645",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 29311131",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 29424242",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
],
[
"R-HSA-9647999",
"RCE1 cleaves S-Farn proRAS proteins",
"endoplasmic reticulum membrane",
" 9851253",
"R-HSA-9648002",
"",
"After prenylation, RAS proteins undergo C-terminal endoproteolysis by RAS-converting enzyme I (RCE1), which removes the aaX residues of the CaaX motif (Otto et al, 1999; Hollander et al, 2000; reviewed in Hampton et al, 2018; Ahearn et al, 2018). RCE1-mediated cleavage is required for RAS plasma membrane localization and function (Michaelson et al, 2005). RCE1 is ubiquitinated in its active form, and deubiquitination by USP17L2 abrogates its catalytic activity and inhibits signaling through the RAS-RAF MAP kinase pathway (Burrows et al, 2009). RCE1 has thus been investigated as a potential therapeutic target in RAS driven disease. Despite some promising studies, the effects of RCE1 inactivation appear unpredictable and can lead to unexpected activation of RAS signaling through mechanisms that are not fully understood (Bergo et al, 2002; Aiyagari et al, 2003; Kim et al, 1999; Chen et al, 1998; Chen et al, 1999; Wahlstrom et al, 2007)."
]
]
},
"readme": "Name\n - Human Protein Reactions (Reactome)\n\nVersion\n - 1.11.2\n\nCreated on\n - 2019-11-30T15:06:36.890527\n\nModified on\n - 2020-04-11T11:29:06.501899\n\nCreated by\n - Jeet Vora [jeetvora@gwu.edu], Rahi Navelkar [rsn13@gwu.edu], Robel Kahsay [rykahsay@gwu.edu], Xavier Holmes [xavierh@email.gwu.edu], Karina Martinez [karinamartinez@gwu.edu], Amanda Bell [amandab2140@gwu.edu], Jonathon Keeney [keeneyjg@gwu.edu], Millicent Quartey [mquartey@email.gwu.edu]\n\nAuthors\n - Maria Martin [martin@ebi.ac.uk], Preethi Vasudev [pvasudev@ebi.ac.uk]\n\nChecksum\n - \n\nUsability Domain\n - The Human Protein Reactions (Reactome) dataset contains reactions information for pathways for human [taxid:9606] UniProtKB accessions that includes reaction participants, pathway ID, reaction ID, PMID etc from Reactome database. The dataset is derived from 2019-09 UniProtKB release. If you use this dataset please provide proper attribution to EMBL-EBI-UniProtKB and GlyGen\n\nDescription Domain\n Keywords\n - Reactome\n - Pathway\n - Reactions\n - PMID\n\n Pipeline Steps\n - Step-1: The script loads the Reactome reaction data from the triplestore containing triples from nt file to retrieve the information associated with the Reactome IDs and maps it to the UniProtKB canonical accessions and extracts the dataset in the csv format\n\nExecution Domain\n Scripts - https://github.com/GW-HIVE/glygen-backend-integration/blob/master/pipeline/integrator/make-protein-dataset.py\n\n\n Software Prerequisites\n Name: Python\n Version: 2.7.5\n URI: https://www.python.org/download/releases/2.7.5/\n\nI/O Domain\n Input Subdomain\n Name: uniprot-proteome-homo-sapiens.nt\n URI: https://data.glygen.org/ln2wwwdata/source/uniprot-proteome-homo-sapiens.nt\n Name: human_protein_masterlist.csv\n URI: https://data.glygen.org/ln2wwwdata/reviewed/human_protein_masterlist.csv\n Output Subdomain\n Name: human_protein_reactions_reactome.csv\n URI: http://data.glygen.org/ln2wwwdata/reviewed/human_protein_reactions_reactome.csv\n Name: human_protein_reactions_reactome.stat.csv\n URI: http://data.glygen.org/ln2wwwdata/reviewed/human_protein_reactions_reactome.stat.csv\n\nFields\n Name: \"uniprotkb_canonical_ac\"\n Description: \"\"\n Unique Values: \"16\"\n Name: \"motif_start\"\n Description: \"\"\n Unique Values: \"23\"\n Name: \"filter_flags\"\n Description: \"Filter tags/flags assigned to the mutation entries that have passed the mutation filter criteria\"\n Unique Values: \"19\"\n Name: \"sift_prediction\"\n Description: \"The SIFT qualitative prediction is derived from this score such that substitutions with a score < 0.05 are called 'deleterious' and all others are called 'tolerated\"\n Unique Values: \"3\"\n Name: \"somatic_status\"\n Description: \"The status of the variant whether it is germline (somatic status =0) or somatic (somatic status =1) variant\"\n Unique Values: \"1\"\n Name: \"chr_pos\"\n Description: \"Chromosome Position of a gene\"\n Unique Values: \"19\"\n Name: \"chr_id\"\n Description: \"\"\n Unique Values: \"10\"\n Name: \"dbsnp_id\"\n Description: \"\"A reference SNP ID number\"\n Unique Values: \"19\"\n Name: \"evidence_ECO:0000313\"\n Description: \"A type of evidence that is imported information used in an automatic assertion\"\n Unique Values: \"1\"\n Name: \"xref_id\"\n Description: \"ID of the X-ref\"\n Unique Values: \"19\"\n Name: \"mim_id\"\n Description: \"Disease ID from the OMIM database\"\n Unique Values: \"1\"\n Name: \"description\"\n Description: \"\"\n Unique Values: \"1\"\n Name: \"begin_aa_pos\"\n Description: \"Start position of the amino acid in the sequence of a protein in UniProtKB\"\n Unique Values: \"18\"\n Name: \"cytogenic_band\"\n Description: \"One of the subregions of a chromosome visible microscopically after special staining\"\n Unique Values: \"14\"\n Name: \"aa_pos\"\n Description: \"Position of the amino acid in canonical sequence of protein in the UniProtKB database\"\n Unique Values: \"18\"\n Name: \"ref_aa\"\n Description: \"Reference amino acid residue\"\n Unique Values: \"9\"\n Name: \"sift_score\"\n Description: \"SIFT predicts whether an amino acid substitution is likely to affect protein function based on sequence homology and the physico-chemical similarity between the alternate amino acids. The data we provide for each amino acid substitution is a score and a qualitative prediction (either 'tolerated' or 'deleterious'). The score is the normalized probability that the amino acid change is tolerated so scores nearer zero are more likely to be deleterious. The qualitative prediction is derived from this score such that substitutions with a score < 0.05 are called 'deleterious' and all others are called 'tolerated\"\n Unique Values: \"10\"\n Name: \"alt_motif\"\n Description: \"Altered motif\"\n Unique Values: \"24\"\n Name: \"disease_xrefs\"\n Description: \"\"\n Unique Values: \"1\"\n Name: \"polyphen_score\"\n Description: \"The score assigned to a amino acid substitution by a tool called as PolyPhen (=Polymorphism Phenotyping) which predicts possible impact of an amino acid substitution on the structure and function of a human protein using straightforward physical and comparative considerations. The PolyPhen score ranges from 0.0 (tolerated) to 1.0 (deleterious). Variants with scores of 0.0 are predicted to be benign. Values closer to 1.0 are more confidently predicted to be deleterious\"\n Unique Values: \"1\"\n Name: \"polyphen_prediction\"\n Description: \"\"The PolyPhen prediction values are - greater than 0.908 - \"\"Probably Damaging\"\"; greater than 0.446 and less than or equal to 0.908 - \"\"Possibly Damaging\"\"; less than or equal to 0.446 - \"\"Benign\"\"\"\n Unique Values: \"1\"\n Name: \"is_known_glycoprotein\"\n Description: \"Yes or no flag to denote if a protein is experimentally proven glycoprotein\"\n Unique Values: \"1\"\n Name: \"alt_nt\"\n Description: \"Alternative nucleotide\"\n Unique Values: \"1\"\n Name: \"protein_name\"\n Description: \"Protein name in the UniProtKB\"\n Unique Values: \"16\"\n Name: \"disease_evidence_ECO:0000313\"\n Description: \"The evidence that could be a PMID or a ClinVar ID that associates disease with the variant\"\n Unique Values: \"1\"\n Name: \"effect\"\n Description: \"The effect on glycosylation or N-sequon due to variation at site of glycosylated amino acid.\"\n Unique Values: \"3\"\n Name: \"end_aa_pos\"\n Description: \"End position of the amino acid in the sequence of a protein in UniProtKB\"\n Unique Values: \"18\"\n Name: \"mutation_type\"\n Description: \"Denotes whether mutation was reported with reference to amino acid or nucleotide\"\n Unique Values: \"1\"\n Name: \"disease_description\"\n Description: \"The disease description and/or definition \"\n Unique Values: \"1\"\n Name: \"do_id\"\n Description: \"Disease Ontology identifier\"\n Unique Values: \"1\"\n Name: \"evidence_ECO:0000269\"\n Description: \"A type of experimental evidence that is used in a manual assertion. Usually the values are PMIDs\"\n Unique Values: \"1\"\n Name: \"ref_nt\"\n Description: \"Reference nucleotide\"\n Unique Values: \"4\"\n Name: \"disease\"\n Description: \"The disease name for the cell line\"\n Unique Values: \"1\"\n Name: \"alt_aa\"\n Description: \"Altered amino acid residue\"\n Unique Values: \"10\"\n Name: \"cosmic_id\"\n Description: \"Legacy mutation identifier (COSM) in Catalogue of Somatic Mutations in Cancer (COSMIC) represents existing COSM mutation identifiers. This identifier remains the same between different assemblies (GRCh37 and GRCh38). All the COSM ids at the same genomic location have been collapsed into one representative COSM id. These ids are maintained to help track existing mutations\"\n Unique Values: \"1\"\n Name: \"ref_motif\"\n Description: \"Reference motif\"\n Unique Values: \"20\"\n Name: \"xref_key\"\n Description: \"Source key associated to the xref_id\"\n Unique Values: \"2\"\n Name: \"minor_allelic_frequency\"\n Description: \"\"\n Unique Values: \"1\"\n Name: \"gene_name\"\n Description: \"\"Official gene name/symbol assigned to the gene. Human gene name/symbol are approved by the HUGO Gene Nomenclature Committee (HGNC) and mouse gene name are approved by the Mouse Genome Informatics (MGI)\"\n Unique Values: \"17\"\n Name: \"disease_evidence_ECO:0000269\"\n Description: \"The PMID evidence for the association of the disease with the variant.\"\n Unique Values: \"1\"",
"downloadurl": "/ln2data/releases/data/v-1.11.2/reviewed/human_protein_reactions_reactome.csv"
}